Outpace Bio

Outpace Bio is a biotechnology company revolutionizing cell therapy through advanced protein design. The company is focused on curing solid tumors by programming cells to make better decisions inside the body, enhancing immune responses and maximizing the potency, specificity, and safety of cell therapies. Outpace Bio uses AI-powered protein design to create new proteins and guide engineered cells in recognizing and eliminating cancer. Its platform technologies, such as OUTSMART™, OUTLAST™, and CO-LOCKR™, aim to solve the complex mechanisms that hinder effective cancer treatment. The company aspires to create curative cell therapy products that can address a wide range of cancer indications, leveraging a deep understanding of biology and technology.